Meridian Bioscience (VIVO) Tops Q4 EPS by 3c
Tweet
Share
E-mailGet Alerts VIVO Hot Sheet
Price: $4.08 +0.74%
Financial Fact:
DIVIDENDS DECLARED PER COMMON SHARE: 0.2
Today's EPS Names:
FWDI, GO, BATL, More
Financial Fact:
DIVIDENDS DECLARED PER COMMON SHARE: 0.2
Today's EPS Names:
FWDI, GO, BATL, More
Join SI Premium – FREE
Meridian Bioscience (NASDAQ: VIVO) reported Q4 EPS of $0.23, $0.03 better than the analyst estimate of $0.20. Revenue for the quarter came in at $76.2 million versus the consensus estimate of $68.4 million.
GUIDANCE:
Meridian Bioscience sees FY2022 EPS of $0.98-$1.08, versus the consensus of $1.63. Meridian Bioscience sees FY2022 revenue of $285-300 million, versus the consensus of $310 million.
For earnings history and earnings-related data on Meridian Bioscience (VIVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Octave Intelligence plc (OCTV) Tops Q2 EPS by 4c ; Offers Guidance
- Sutro Biopharma Inc. (STRO) Misses Q2 EPS by 13c
- Avino Silver & Gold Mines (ASM) Misses Q2 EPS by 4c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
